OncoPro NCCN Lung Cancer Panel Test
Comprehensive Genetic Analysis for Lung Cancer Treatment
The OncoPro NCCN Lung Cancer Panel Test represents a cutting-edge approach to lung cancer diagnosis and treatment planning. This comprehensive genetic panel utilizes next-generation sequencing technology to analyze critical mutations in lung cancer tumors, providing oncologists with essential information to guide personalized treatment decisions. Developed in accordance with NCCN guidelines, this test helps identify patients who may benefit from targeted therapies, potentially transforming lung cancer management from a one-size-fits-all approach to precision medicine.
What This Advanced Test Detects
The OncoPro NCCN Lung Cancer Panel Test measures and detects mutations across 10 crucial genes known to drive lung cancer progression:
- EGFR – Epidermal Growth Factor Receptor mutations
- ALK – Anaplastic Lymphoma Kinase rearrangements
- ERBB2 – HER2 receptor tyrosine kinase mutations
- BRAF – B-Raf proto-oncogene mutations
- MET – Mesenchymal-epithelial transition factor alterations
- RET – Rearranged during transfection fusions
- ROS1 – ROS proto-oncogene 1 rearrangements
- NTRK1 – Neurotrophic tyrosine receptor kinase fusions
- KRAS – Kirsten rat sarcoma viral oncogene mutations
- MSI – Microsatellite instability status
Who Should Consider This Genetic Testing
This comprehensive lung cancer panel is particularly recommended for:
- Patients newly diagnosed with non-small cell lung cancer (NSCLC)
- Individuals with advanced or metastatic lung cancer
- Patients who have experienced progression on initial therapy
- Those with a family history of lung cancer or genetic predisposition
- Individuals seeking targeted therapy options beyond conventional chemotherapy
- Patients with adenocarcinoma histology
- Never-smokers or light smokers diagnosed with lung cancer
Key Benefits of OncoPro NCCN Lung Cancer Testing
- Personalized Treatment Planning – Identifies specific genetic alterations that respond to targeted therapies
- Comprehensive Mutation Analysis – Tests multiple genes simultaneously for efficient diagnosis
- Guideline-Compliant – Follows NCCN recommendations for comprehensive biomarker testing
- Non-Invasive Option – Uses liquid biopsy technology requiring only blood sample
- Treatment Optimization – Helps avoid ineffective treatments and associated side effects
- Prognostic Information – Provides insights into disease progression and potential outcomes
- Clinical Trial Eligibility – Identifies patients who may qualify for targeted therapy trials
Understanding Your Test Results
Your OncoPro NCCN Lung Cancer Panel results will provide detailed information about detected genetic mutations:
- Positive Results – Indicate specific genetic alterations that may respond to targeted therapies
- Negative Results – Suggest standard treatment approaches may be more appropriate
- Actionable Mutations – Identified alterations with available targeted treatments
- Emerging Biomarkers – Genetic changes that may inform future treatment options
- MSI Status – Microsatellite instability results that may indicate immunotherapy benefit
Your oncologist will interpret these results in the context of your specific diagnosis and medical history to develop the most effective treatment plan.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $2926 |
| Regular Price | $3250 |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York City, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee. Our network ensures accessible testing for patients nationwide.
Take Control of Your Lung Cancer Journey
Don’t leave your treatment decisions to chance. The OncoPro NCCN Lung Cancer Panel Test provides the critical genetic information needed to pursue the most effective targeted therapies. With our discounted price of $2926 USD, this comprehensive testing is more accessible than ever.
Ready to get started? Book your OncoPro NCCN Lung Cancer Panel Test today by calling our dedicated healthcare team at +1(267) 388-9828 or schedule your appointment online. Take the first step toward personalized lung cancer treatment.
